U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
REMITOGEN
Preferred Name English
APOLIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
Apolizumab [WHO-DD]
Common Name English
HU1D10
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN HISTOCOMPATIBILITY ANTIGEN HLA-DR) (HUMAN-MOUSE MONOCLONAL HU1D10.GAMMA.(SUB 1)-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HU1D10 LIGHT CHAIN, DIMER
Common Name English
APOLIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN HISTOCOMPATIBILITY ANTIGEN HLA-DR) (HUMAN-MOUSE MONOCLONAL HU1D10.GAMMA.(SUB 1)-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HU1D10 LIGHT CHAIN, DIMER. MOLECULAR WEIGHT IS APPROXIMATELY 150,000 DALTONS
Common Name English
HU-1D10
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN HISTOCOMPATIBILITY ANTIGEN HLA-DR) (HUMAN-MOUSE MONOCLONAL HU1D10.GAMMA.(SUB 1)-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HU1D10 LIGHT CHAIN, DIMER
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN HISTOCOMPATIBILITY ANTIGEN HLA-DR) (HUMAN-MOUSE MONOCLONAL HU1D10.GAMMA.(SUB 1)-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HU1D10 LIGHT CHAIN, DIMER. MOLECULAR WEIGHT IS APPROXIMATELY 150,000 DALTONS
Common Name English
apolizumab [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
FDA ORPHAN DRUG 144701
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
Code System Code Type Description
CAS
267227-08-7
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108252
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
WIKIPEDIA
APOLIZUMAB
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
DRUG BANK
DB06467
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
FDA UNII
G88KCP51RE
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
INN
8210
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
NCI_THESAURUS
C2228
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
SMS_ID
300000021879
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
USAN
NN-26
Created by admin on Mon Mar 31 20:34:06 GMT 2025 , Edited by admin on Mon Mar 31 20:34:06 GMT 2025
PRIMARY
ACTIVE MOIETY
APOLIZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966